CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：112/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：43/0  |  提交时间：2020/01/03
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Xiong, Jianping;  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. 期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 卷号: 36, 期号: 30, 页码: JCO2018783183
作者:  Qin, Shukui;  Li, Jin*;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng
收藏  |  浏览/下载：26/0  |  提交时间：2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2, 页码: 315-322
作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Wu, Jianqiu;  Song, Yongping;  Su, Liping;  Xu, Li;  Chen, Tingchao
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/04

©版权所有 ©2017 CSpace - Powered by CSpace